Everett, B.M., Smith, R.J., Hiatt, W.R., Reducing ldl with pcsk9 inhibitors -The clinical benefit of lipid drugs (2015) N Engl J Med, 373, pp. 1588-1591
Flierl, U., Nero, T.L., Lim, B., Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators (2015) J Exp Med, 212, pp. 129-137
Korporaal, S.J., Van Eck, M., Adelmeijer, J., Platelet activation by oxidized low density lipoprotein is mediated by cd36 and scavenger receptor-A (2007) Arterioscler Thromb Vasc Biol, 27, pp. 2476-2483
